Abstract
Allosteric enhancers at the adenosine A1 receptor have received attention as anti-arrhythmic cardiac agents, and, more recently, as anti-lipolytic agents. In addition, allosteric modulators at the adenosine A1 receptor have therapeutic potential as analgesics and neuroprotective agents. In particular, the compounds with improved potency as enhancers and reduced antagonist properties are mentioned.
Keywords: A1-adenosine receptor, allosteric modulators, enhancer, cAMP content, neuroprotection
Mini-Reviews in Medicinal Chemistry
Title: Allosteric Enhancers for A1 Adenosine Receptor
Volume: 7 Issue: 6
Author(s): Pier Giovanni Baraldi, Maria Antonietta Iaconinoto, Allan R. Moorman, Maria Dora Carrion, Carlota Lopez Cara, Delia Preti, Olga Cruz Lopez, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi and Romeo Romagnoli
Affiliation:
Keywords: A1-adenosine receptor, allosteric modulators, enhancer, cAMP content, neuroprotection
Abstract: Allosteric enhancers at the adenosine A1 receptor have received attention as anti-arrhythmic cardiac agents, and, more recently, as anti-lipolytic agents. In addition, allosteric modulators at the adenosine A1 receptor have therapeutic potential as analgesics and neuroprotective agents. In particular, the compounds with improved potency as enhancers and reduced antagonist properties are mentioned.
Export Options
About this article
Cite this article as:
Pier Giovanni Baraldi , Maria Antonietta Iaconinoto , Allan R. Moorman , Maria Dora Carrion , Carlota Lopez Cara , Delia Preti , Olga Cruz Lopez , Francesca Fruttarolo , Mojgan Aghazadeh Tabrizi and Romeo Romagnoli , Allosteric Enhancers for A1 Adenosine Receptor, Mini-Reviews in Medicinal Chemistry 2007; 7 (6) . https://dx.doi.org/10.2174/138955707780859459
DOI https://dx.doi.org/10.2174/138955707780859459 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: Oxidative Stress in Pathophysiological Conditions
Current Vascular Pharmacology Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology Clinical Aspects of Melatonin in the Acute Coronary Syndrome
Current Vascular Pharmacology Pathophysiology of Erectile Dysfunction
Current Drug Targets Common Therapeutic Strategies in the Management of Sexual Dysfunction and Cardiovascular Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy
Current Molecular Medicine Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Cholinesterase Inhibitors Slow Decline in Executive Functions, Rather than Memory, in Alzheimers Disease: A 1-Year Observational Study in the Sunnybrook Dementia Cohort
Current Alzheimer Research MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Genetic Markers in Biological Fluids for Aging-Related Major Neurocognitive Disorder
Current Alzheimer Research Discovery Approaches for Novel Dyslipidemia Drugs
Current Drug Discovery Technologies Guidelines and their Implementation: A Discussion Document Focused on the Best Approaches to Drive Improvement
Vascular Disease Prevention (Discontinued) Patent Annotations
Recent Patents on Cardiovascular Drug Discovery Proteasomal Inhibition: A Novel Pathway for Prevention of Atherosclerosis and Restenosis
Vascular Disease Prevention (Discontinued) Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure
Current Pharmaceutical Design Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy
Current Pediatric Reviews The Protective Role of Heme Oxygenase-1 in Cerebral Ischemia
Central Nervous System Agents in Medicinal Chemistry A Possible New Diagnostic Biomarker in Early Diagnosis of Alzheimers Disease
Current Alzheimer Research Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders
Current Medicinal Chemistry Atypical Chest Pain in ACS: A Trap Especially for Women
Current Pharmaceutical Design